Acorda Therapeutics, Inc.
ACOR · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9 | $30 | $32 | $25 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $9 | $17 | $12 | $13 |
| Inventory | $14 | $16 | $18 | $15 |
| Other Curr. Assets | $16 | $11 | $11 | $11 |
| Total Curr. Assets | $48 | $75 | $74 | $65 |
| Property Plant & Equip (Net) | $6 | $6 | $7 | $7 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $22 | $23 | $282 | $290 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $9 | -$0 | -$0 |
| Other NC Assets | $5 | $4 | $4 | $3 |
| Total NC Assets | $33 | $43 | $293 | $300 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $82 | $118 | $366 | $365 |
| Liabilities | – | – | – | – |
| Payables | $10 | $15 | $12 | $3 |
| Short-Term Debt | $193 | $188 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $1 |
| Other Curr. Liab. | $21 | $26 | $32 | $25 |
| Total Curr. Liab. | $224 | $228 | $46 | $30 |
| LT Debt | $3 | $3 | $185 | $180 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $9 | $39 | $40 |
| Other NC Liab. | $41 | $36 | $38 | $47 |
| Total NC Liab. | $43 | $48 | $261 | $266 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $267 | $276 | $307 | $297 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $962 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,217 | -$1,189 | -$971 | -$962 |
| AOCI | $1 | $1 | $1 | $1 |
| Other Equity | $1,030 | $1,030 | $1,030 | $68 |
| Total Equity | -$186 | -$158 | $59 | $68 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $82 | $118 | $366 | $365 |
| Net Debt | $187 | $161 | $154 | $156 |